| Dr Hiro Makino, MD | |
|
98-1247 Kaahumanu St, Suite 208, Aiea, HI 96701-5311 | |
| (808) 486-6116 | |
| (808) 486-7987 |
| Full Name | Dr Hiro Makino |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 47 Years |
| Location | 98-1247 Kaahumanu St, Aiea, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467494732 | NPI | - | NPPES |
| 055626 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD5668 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Eureka, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Medical Foundation | 8921993205 | 1293 |
News Archive
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the presentation of data for its lead drug candidate, ANG1005, a novel paclitaxel-peptide drug conjugate, at the American Society of Clinical Oncology 50th Annual Meeting in Chicago, IL.
QPharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today the official release of their aggregate spend solution, qSpend. This tool assists Pharmaceutical, Biotechnology, and Medical Device companies in complying with countless state and federal laws, regulations, and industry guidelines governing sales and marketing. qSpend is QPharma's cost-efficient, aggregate spend solution for tracking, evaluating, and reporting sales and marketing expenditures in a regulatory compliant manner.
The use of social media by older people can offer valuable additional support in cases of sickness and diseases, new research from the University of Luxembourg has shown.
Rapid information processing in the nervous system requires synapses, specialized contact sites between nerve cells and their targets. One particular synapse type, cholinergic, uses the chemical transmitter acetylcholine to communicate between nerve cells. Cholinergic synapses are essential for normal learning and memory, arousal, attention, and all autonomic (involuntary) nervous system functions.
› Verified 8 days ago
| Entity Name | Providence Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285890624 PECOS PAC ID: 8921993205 Enrollment ID: O20040216001346 |
News Archive
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the presentation of data for its lead drug candidate, ANG1005, a novel paclitaxel-peptide drug conjugate, at the American Society of Clinical Oncology 50th Annual Meeting in Chicago, IL.
QPharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today the official release of their aggregate spend solution, qSpend. This tool assists Pharmaceutical, Biotechnology, and Medical Device companies in complying with countless state and federal laws, regulations, and industry guidelines governing sales and marketing. qSpend is QPharma's cost-efficient, aggregate spend solution for tracking, evaluating, and reporting sales and marketing expenditures in a regulatory compliant manner.
The use of social media by older people can offer valuable additional support in cases of sickness and diseases, new research from the University of Luxembourg has shown.
Rapid information processing in the nervous system requires synapses, specialized contact sites between nerve cells and their targets. One particular synapse type, cholinergic, uses the chemical transmitter acetylcholine to communicate between nerve cells. Cholinergic synapses are essential for normal learning and memory, arousal, attention, and all autonomic (involuntary) nervous system functions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hiro Makino, MD 98-1247 Kaahumanu St, Suite 208, Aiea, HI 96701-5311 Ph: (808) 486-6116 | Dr Hiro Makino, MD 98-1247 Kaahumanu St, Suite 208, Aiea, HI 96701-5311 Ph: (808) 486-6116 |
News Archive
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the presentation of data for its lead drug candidate, ANG1005, a novel paclitaxel-peptide drug conjugate, at the American Society of Clinical Oncology 50th Annual Meeting in Chicago, IL.
QPharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today the official release of their aggregate spend solution, qSpend. This tool assists Pharmaceutical, Biotechnology, and Medical Device companies in complying with countless state and federal laws, regulations, and industry guidelines governing sales and marketing. qSpend is QPharma's cost-efficient, aggregate spend solution for tracking, evaluating, and reporting sales and marketing expenditures in a regulatory compliant manner.
The use of social media by older people can offer valuable additional support in cases of sickness and diseases, new research from the University of Luxembourg has shown.
Rapid information processing in the nervous system requires synapses, specialized contact sites between nerve cells and their targets. One particular synapse type, cholinergic, uses the chemical transmitter acetylcholine to communicate between nerve cells. Cholinergic synapses are essential for normal learning and memory, arousal, attention, and all autonomic (involuntary) nervous system functions.
› Verified 8 days ago
Dr. Dawn A. Miura, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 350, Aiea, HI 96701 Phone: 808-487-2277 Fax: 808-488-5582 | |
Dr. Michael Wayne Chan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 655, Aiea, HI 96701 Phone: 808-486-6200 | |
Dr. Craig Yoshio Hamasaki, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98-1247 Kaahumanu Street, Suite 224, Aiea, HI 96701 Phone: 808-486-9119 Fax: 808-486-9401 | |
Dr. Kevin Scott Hara, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 430, Aiea, HI 96701 Phone: 808-484-2000 Fax: 808-488-6580 | |
Shayne Mark Castanera, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-486-6000 | |
Dr. Ky H Le, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98-199 Kamehameha Hwy Unit C-10b, Aiea, HI 96701 Phone: 808-954-4500 Fax: 808-758-0146 | |
Dr. Malissa Hyun Kyung Iida-takashima, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Ste 500, Aiea, HI 96701 Phone: 808-488-0990 |